亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Best step-up treatments for children with uncontrolled asthma: a systematic review and network meta-analysis of individual participant data

医学 哮喘 荟萃分析 安慰剂 系统回顾 临床试验 恶化 心理干预 梅德林 物理疗法 内科学 儿科 替代医学 护理部 法学 病理 政治学
作者
Sofia Cividini,Ian Sinha,Sarah Donegan,Michelle Maden,Katie Rose,Olivia Fulton,Giovanna Culeddu,Dyfrig Hughes,Steve Turner,Catrin Tudur Smith
出处
期刊:The European respiratory journal [European Respiratory Society]
卷期号:62 (6): 2301011-2301011 被引量:1
标识
DOI:10.1183/13993003.01011-2023
摘要

Background There is uncertainty about the best treatment option for children/adolescents with uncontrolled asthma despite inhaled corticosteroids (ICS) and international guidelines make different recommendations. We evaluated the pharmacological treatments to reduce asthma exacerbations and symptoms in uncontrolled patients age <18 years on ICS. Methods We searched MEDLINE, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, Embase, Web of Science, National Institute for Health and Care Excellence Technology Appraisals, National Institute for Health and Care Research Health Technology Assessment series, World Health Organization International Clinical Trials Registry, conference abstracts and internal clinical trial registers (1 July 2014 to 5 May 2023) for randomised controlled trials of participants age <18 years with uncontrolled asthma on any ICS dose alone at screening. Studies before July 2014 were retrieved from previous systematic reviews/contact with authors. Patients had to be randomised to any dose of ICS alone or combined with long-acting β 2 -agonists (LABA) or combined with leukotriene receptor antagonists (LTRA), LTRA alone, theophylline or placebo. Primary outcomes were exacerbation and asthma control. The interventions evaluated were ICS (low/medium/high dose), ICS+LABA, ICS+LTRA, LTRA alone, theophylline and placebo. Results Of the 4708 publications identified, 144 trials were eligible. Individual participant data were obtained from 29 trials and aggregate data were obtained from 19 trials. Compared with ICS Low, ICS Medium+LABA was associated with the lowest odds of exacerbation (OR 0.44, 95% credibility interval (95% CrI) 0.19–0.90) and with an increased forced expiratory volume in 1 s (mean difference 0.71, 95% CrI 0.35–1.06). Treatment with LTRA was the least preferred. No apparent differences were found for asthma control. Conclusions Uncontrolled children/adolescents on low-dose ICS should be recommended a change to medium-dose ICS+LABA to reduce the risk for exacerbation and improve lung function.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Nole的应助被369ninja采纳,获得10
1秒前
zhiwei发布了新的文献求助10
2秒前
6秒前
拼搏碧曼完成签到,获得积分10
6秒前
CTShih的应助被369ninja采纳,获得10
16秒前
zhiwei发布了新的文献求助10
29秒前
33秒前
Orange的应助被369ninja采纳,获得10
35秒前
37秒前
威武的成协完成签到,获得积分10
43秒前
369ninja发布了新的文献求助10
44秒前
李健的小迷弟的应助被369ninja采纳,获得10
49秒前
淡水美人鱼完成签到,获得积分10
55秒前
57秒前
敏感的黄蜂完成签到,获得积分10
58秒前
在水一方的应助被科研通管家采纳,获得10
1分钟前
FashionBoy的应助被369ninja采纳,获得10
1分钟前
zhiwei发布了新的文献求助30
1分钟前
1分钟前
不安平松完成签到,获得积分10
1分钟前
CTShih的应助被369ninja采纳,获得10
1分钟前
jialinding发布了新的文献求助10
1分钟前
小巧的水杯完成签到 ,获得积分10
1分钟前
obaica完成签到,获得积分10
1分钟前
zhiwei发布了新的文献求助10
1分钟前
1分钟前
细腻海瑶完成签到,获得积分10
1分钟前
zhiwei发布了新的文献求助10
1分钟前
2分钟前
orixero的应助被369ninja采纳,获得10
2分钟前
悦耳的翠绿完成签到,获得积分10
2分钟前
小新小新完成签到 ,获得积分10
2分钟前
Nole的应助被369ninja采纳,获得10
2分钟前
2分钟前
tszjw168完成签到 ,获得积分10
2分钟前
Owen的应助被369ninja采纳,获得10
2分钟前
2分钟前
愉快飞薇完成签到,获得积分10
2分钟前
zhiwei发布了新的文献求助10
2分钟前
感动的天德完成签到,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179956
求助须知:如何正确求助?哪些是违规求助? 9570170
关于积分的说明 21808464
捐赠科研通 7775818
什么是DOI,文献DOI怎么找? 3433251
关于科研通互助平台的介绍 2557361
邀请新用户注册赠送积分活动 2478958